These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22403507)

  • 1. Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates.
    Shin DY; Ku CR; Kim KM; Choi HS; Rhee Y; Lee EJ; Lim SK
    Korean J Intern Med; 2012 Mar; 27(1):98-102. PubMed ID: 22403507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
    Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical femoral fractures in bisphosphonate therapy].
    Ballaschk A; Kalaitzis N; Röpke M; Piatek S
    Unfallchirurg; 2015 Jan; 118(1):88-91. PubMed ID: 24352201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Bögl HP; Aspenberg P; Schilcher J
    Osteoporos Int; 2017 Aug; 28(8):2439-2444. PubMed ID: 28474166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
    Koh A; Guerado E; Giannoudis PV
    Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?
    Ha YC; Cho MR; Park KH; Kim SY; Koo KH
    Clin Orthop Relat Res; 2010 Dec; 468(12):3393-8. PubMed ID: 20865463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous Bilateral Femoral Fractures After High-Dose Zoledronic Acid.
    Brin YS; Palmanovich E; Heler Z; Kish BJ; Nyska M; Bismuth H; Coughlin R; Zehavi T; Rotman P
    Orthopedics; 2015 Nov; 38(11):e1051-4. PubMed ID: 26558671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
    Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
    Reddy SV; Gupta SK
    Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
    Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
    Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
    Ing-Lorenzini K; Desmeules J; Plachta O; Suva D; Dayer P; Peter R
    Drug Saf; 2009; 32(9):775-85. PubMed ID: 19670917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical fractures of the femur: apropos of 3 clinical cases].
    Sanduloviciu M; Stoll D; Lamy O; Krieg MA; Aubry-Rozier B
    Praxis (Bern 1994); 2014 Aug; 103(16):939-44. PubMed ID: 25097162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.
    Fernandes TL; Viezzer Fernandes B; Jitumori C; Franco GCN
    Am J Case Rep; 2023 Oct; 24():e941144. PubMed ID: 37867315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
    Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
    Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and their influence on fracture healing: a systematic review.
    Molvik H; Khan W
    Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
    Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
    J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.